nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CYP3A4—Fingolimod—multiple sclerosis	0.0783	0.246	CbGbCtD
Isradipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0505	0.158	CbGbCtD
Isradipine—CYP3A4—Triamcinolone—multiple sclerosis	0.0382	0.12	CbGbCtD
Isradipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0368	0.116	CbGbCtD
Isradipine—CYP3A4—Betamethasone—multiple sclerosis	0.0328	0.103	CbGbCtD
Isradipine—CYP3A4—Prednisolone—multiple sclerosis	0.0324	0.102	CbGbCtD
Isradipine—CYP3A4—Prednisone—multiple sclerosis	0.0306	0.096	CbGbCtD
Isradipine—CYP3A4—Dexamethasone—multiple sclerosis	0.0191	0.0599	CbGbCtD
Isradipine—CACNB2—retina—multiple sclerosis	0.00446	0.0651	CbGeAlD
Isradipine—CACNA1H—NCAM1 interactions—PRNP—multiple sclerosis	0.00436	0.0376	CbGpPWpGaD
Isradipine—CACNA2D1—brainstem—multiple sclerosis	0.00434	0.0634	CbGeAlD
Isradipine—CACNA2D2—midbrain—multiple sclerosis	0.00385	0.0562	CbGeAlD
Isradipine—CACNA2D2—spinal cord—multiple sclerosis	0.00375	0.0548	CbGeAlD
Isradipine—CACNA1S—NCAM1 interactions—PRNP—multiple sclerosis	0.0037	0.0319	CbGpPWpGaD
Isradipine—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.0033	0.0284	CbGpPWpGaD
Isradipine—CACNB2—NCAM1 interactions—PRNP—multiple sclerosis	0.00317	0.0273	CbGpPWpGaD
Isradipine—CACNA2D2—nervous system—multiple sclerosis	0.00316	0.0462	CbGeAlD
Isradipine—CACNA2D2—central nervous system—multiple sclerosis	0.00305	0.0444	CbGeAlD
Isradipine—CACNA1D—NCAM1 interactions—PRNP—multiple sclerosis	0.003	0.0259	CbGpPWpGaD
Isradipine—CACNA2D2—cerebellum—multiple sclerosis	0.00298	0.0434	CbGeAlD
Isradipine—CACNA1C—NCAM1 interactions—PRNP—multiple sclerosis	0.00264	0.0228	CbGpPWpGaD
Isradipine—CACNA1H—nervous system—multiple sclerosis	0.00257	0.0374	CbGeAlD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00256	0.0221	CbGpPWpGaD
Isradipine—CACNB2—nervous system—multiple sclerosis	0.00242	0.0354	CbGeAlD
Isradipine—CACNA2D2—brain—multiple sclerosis	0.00242	0.0353	CbGeAlD
Isradipine—CACNA1H—cerebellum—multiple sclerosis	0.00241	0.0352	CbGeAlD
Isradipine—CACNA2D2—Neuronal System—KCNA3—multiple sclerosis	0.00238	0.0205	CbGpPWpGaD
Isradipine—CACNB2—central nervous system—multiple sclerosis	0.00233	0.034	CbGeAlD
Isradipine—CACNB2—cerebellum—multiple sclerosis	0.00228	0.0333	CbGeAlD
Isradipine—CACNA2D1—nervous system—multiple sclerosis	0.00227	0.0332	CbGeAlD
Isradipine—CACNA1H—Axon guidance—CD24—multiple sclerosis	0.00223	0.0192	CbGpPWpGaD
Isradipine—CACNA2D1—central nervous system—multiple sclerosis	0.00219	0.032	CbGeAlD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00218	0.0187	CbGpPWpGaD
Isradipine—CACNA2D1—cerebellum—multiple sclerosis	0.00214	0.0312	CbGeAlD
Isradipine—CACNA1D—nervous system—multiple sclerosis	0.00212	0.0309	CbGeAlD
Isradipine—CACNA1D—central nervous system—multiple sclerosis	0.00204	0.0298	CbGeAlD
Isradipine—CACNA1D—cerebellum—multiple sclerosis	0.00199	0.0291	CbGeAlD
Isradipine—CACNA1H—brain—multiple sclerosis	0.00196	0.0286	CbGeAlD
Isradipine—CACNA1C—nervous system—multiple sclerosis	0.00195	0.0285	CbGeAlD
Isradipine—CACNA1S—Axon guidance—CD24—multiple sclerosis	0.00189	0.0163	CbGpPWpGaD
Isradipine—CACNA1C—central nervous system—multiple sclerosis	0.00188	0.0275	CbGeAlD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00187	0.0161	CbGpPWpGaD
Isradipine—CACNB2—brain—multiple sclerosis	0.00185	0.027	CbGeAlD
Isradipine—CACNA1C—cerebellum—multiple sclerosis	0.00184	0.0268	CbGeAlD
Isradipine—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00184	0.0158	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00177	0.0152	CbGpPWpGaD
Isradipine—CACNA2D1—brain—multiple sclerosis	0.00174	0.0254	CbGeAlD
Isradipine—CACNB2—Neuronal System—KCNA3—multiple sclerosis	0.00163	0.014	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—CD24—multiple sclerosis	0.00162	0.014	CbGpPWpGaD
Isradipine—CACNA1D—brain—multiple sclerosis	0.00162	0.0236	CbGeAlD
Isradipine—CACNA1S—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.00162	0.0139	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CD24—multiple sclerosis	0.00159	0.0137	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—PRNP—multiple sclerosis	0.00155	0.0134	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—CD24—multiple sclerosis	0.00154	0.0132	CbGpPWpGaD
Isradipine—CACNA1C—brain—multiple sclerosis	0.00149	0.0218	CbGeAlD
Isradipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00147	0.0127	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—TNFRSF1A—multiple sclerosis	0.0014	0.012	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CD24—multiple sclerosis	0.00135	0.0116	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—CD24—multiple sclerosis	0.00135	0.0116	CbGpPWpGaD
Isradipine—CACNA1D—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.00131	0.0113	CbGpPWpGaD
Isradipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00126	0.0109	CbGpPWpGaD
Isradipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00119	0.0103	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CD24—multiple sclerosis	0.00116	0.00997	CbGpPWpGaD
Isradipine—CACNA1C—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.00115	0.00994	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—TNFRSF1A—multiple sclerosis	0.00113	0.00976	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CD24—multiple sclerosis	0.0011	0.00944	CbGpPWpGaD
Isradipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00105	0.00904	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TNFRSF1A—multiple sclerosis	0.000995	0.00858	CbGpPWpGaD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000968	0.00834	CbGpPWpGaD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000968	0.00834	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CD24—multiple sclerosis	0.000963	0.0083	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—FAS—multiple sclerosis	0.000959	0.00826	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—TLR4—multiple sclerosis	0.000899	0.00775	CbGpPWpGaD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000892	0.00769	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—APOE—multiple sclerosis	0.00088	0.00758	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.00087	0.0075	CbGpPWpGaD
Isradipine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000857	0.00739	CbGpPWpGaD
Isradipine—Angioedema—Methylprednisolone—multiple sclerosis	0.000824	0.00166	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000821	0.00165	CcSEcCtD
Isradipine—Malaise—Triamcinolone—multiple sclerosis	0.000815	0.00164	CcSEcCtD
Isradipine—Malaise—Methylprednisolone—multiple sclerosis	0.000813	0.00164	CcSEcCtD
Isradipine—Syncope—Triamcinolone—multiple sclerosis	0.00081	0.00163	CcSEcCtD
Isradipine—Syncope—Methylprednisolone—multiple sclerosis	0.000808	0.00163	CcSEcCtD
Isradipine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000806	0.00162	CcSEcCtD
Isradipine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000805	0.00162	CcSEcCtD
Isradipine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000802	0.00161	CcSEcCtD
Isradipine—Oedema—Prednisolone—multiple sclerosis	0.000802	0.00161	CcSEcCtD
Isradipine—Dizziness—Azathioprine—multiple sclerosis	0.000799	0.00161	CcSEcCtD
Isradipine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000794	0.0016	CcSEcCtD
Isradipine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000792	0.0016	CcSEcCtD
Isradipine—Shock—Prednisolone—multiple sclerosis	0.000789	0.00159	CcSEcCtD
Isradipine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000789	0.00159	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000788	0.00679	CbGpPWpGaD
Isradipine—Cough—Triamcinolone—multiple sclerosis	0.000788	0.00159	CcSEcCtD
Isradipine—Tachycardia—Prednisolone—multiple sclerosis	0.000782	0.00158	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000782	0.00157	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—FAS—multiple sclerosis	0.000778	0.00671	CbGpPWpGaD
Isradipine—Urticaria—Mitoxantrone—multiple sclerosis	0.000776	0.00156	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000775	0.00156	CcSEcCtD
Isradipine—Vomiting—Azathioprine—multiple sclerosis	0.000769	0.00155	CcSEcCtD
Isradipine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000767	0.00155	CcSEcCtD
Isradipine—Eye disorder—Prednisone—multiple sclerosis	0.000766	0.00154	CcSEcCtD
Isradipine—Anxiety—Methylprednisolone—multiple sclerosis	0.000765	0.00154	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—multiple sclerosis	0.000763	0.00154	CcSEcCtD
Isradipine—Rash—Azathioprine—multiple sclerosis	0.000762	0.00153	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000762	0.00153	CcSEcCtD
Isradipine—Dermatitis—Azathioprine—multiple sclerosis	0.000762	0.00153	CcSEcCtD
Isradipine—Depression—Methotrexate—multiple sclerosis	0.000761	0.00153	CcSEcCtD
Isradipine—Flushing—Prednisone—multiple sclerosis	0.000761	0.00153	CcSEcCtD
Isradipine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000761	0.00153	CcSEcCtD
Isradipine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000761	0.00153	CcSEcCtD
Isradipine—Discomfort—Triamcinolone—multiple sclerosis	0.00076	0.00153	CcSEcCtD
Isradipine—Discomfort—Methylprednisolone—multiple sclerosis	0.000758	0.00153	CcSEcCtD
Isradipine—Headache—Azathioprine—multiple sclerosis	0.000757	0.00152	CcSEcCtD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000757	0.00652	CbGpPWpGaD
Isradipine—Dry mouth—Triamcinolone—multiple sclerosis	0.000752	0.00151	CcSEcCtD
Isradipine—Angioedema—Dexamethasone—multiple sclerosis	0.000749	0.00151	CcSEcCtD
Isradipine—Angioedema—Betamethasone—multiple sclerosis	0.000749	0.00151	CcSEcCtD
Isradipine—Angiopathy—Prednisone—multiple sclerosis	0.000744	0.0015	CcSEcCtD
Isradipine—Immune system disorder—Prednisone—multiple sclerosis	0.000741	0.00149	CcSEcCtD
Isradipine—Malaise—Betamethasone—multiple sclerosis	0.000739	0.00149	CcSEcCtD
Isradipine—Malaise—Dexamethasone—multiple sclerosis	0.000739	0.00149	CcSEcCtD
Isradipine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000737	0.00148	CcSEcCtD
Isradipine—Oedema—Triamcinolone—multiple sclerosis	0.000737	0.00148	CcSEcCtD
Isradipine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000736	0.00148	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—PRNP—multiple sclerosis	0.000735	0.00634	CbGpPWpGaD
Isradipine—Syncope—Betamethasone—multiple sclerosis	0.000735	0.00148	CcSEcCtD
Isradipine—Syncope—Dexamethasone—multiple sclerosis	0.000735	0.00148	CcSEcCtD
Isradipine—Shock—Triamcinolone—multiple sclerosis	0.000725	0.00146	CcSEcCtD
Isradipine—Insomnia—Prednisolone—multiple sclerosis	0.000725	0.00146	CcSEcCtD
Isradipine—Shock—Methylprednisolone—multiple sclerosis	0.000724	0.00146	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000722	0.00145	CcSEcCtD
Isradipine—CYP3A4—nervous system—multiple sclerosis	0.000722	0.0105	CbGeAlD
Isradipine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000721	0.00145	CcSEcCtD
Isradipine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00072	0.00145	CcSEcCtD
Isradipine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00072	0.00145	CcSEcCtD
Isradipine—Paraesthesia—Prednisolone—multiple sclerosis	0.00072	0.00145	CcSEcCtD
Isradipine—Tachycardia—Triamcinolone—multiple sclerosis	0.00072	0.00145	CcSEcCtD
Isradipine—Mental disorder—Prednisone—multiple sclerosis	0.000718	0.00145	CcSEcCtD
Isradipine—Nausea—Azathioprine—multiple sclerosis	0.000718	0.00145	CcSEcCtD
Isradipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000718	0.00145	CcSEcCtD
Isradipine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000715	0.00144	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—APOE—multiple sclerosis	0.000714	0.00616	CbGpPWpGaD
Isradipine—Malnutrition—Prednisone—multiple sclerosis	0.000714	0.00144	CcSEcCtD
Isradipine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000713	0.00144	CcSEcCtD
Isradipine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000711	0.00143	CcSEcCtD
Isradipine—Asthenia—Mitoxantrone—multiple sclerosis	0.000701	0.00141	CcSEcCtD
Isradipine—Anxiety—Betamethasone—multiple sclerosis	0.000695	0.0014	CcSEcCtD
Isradipine—Anxiety—Dexamethasone—multiple sclerosis	0.000695	0.0014	CcSEcCtD
Isradipine—CYP3A4—central nervous system—multiple sclerosis	0.000695	0.0101	CbGeAlD
Isradipine—Discomfort—Dexamethasone—multiple sclerosis	0.00069	0.00139	CcSEcCtD
Isradipine—Discomfort—Betamethasone—multiple sclerosis	0.00069	0.00139	CcSEcCtD
Isradipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000687	0.00138	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—multiple sclerosis	0.000685	0.00138	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—FAS—multiple sclerosis	0.000684	0.00589	CbGpPWpGaD
Isradipine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000677	0.00136	CcSEcCtD
Isradipine—Vision blurred—Prednisone—multiple sclerosis	0.000673	0.00135	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—multiple sclerosis	0.000672	0.00135	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000672	0.00135	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00067	0.00135	CcSEcCtD
Isradipine—Oedema—Betamethasone—multiple sclerosis	0.000669	0.00135	CcSEcCtD
Isradipine—Oedema—Dexamethasone—multiple sclerosis	0.000669	0.00135	CcSEcCtD
Isradipine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000669	0.00135	CcSEcCtD
Isradipine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000669	0.00135	CcSEcCtD
Isradipine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000669	0.00135	CcSEcCtD
Isradipine—Insomnia—Triamcinolone—multiple sclerosis	0.000667	0.00134	CcSEcCtD
Isradipine—CACNA2D2—Neuronal System—BCHE—multiple sclerosis	0.000667	0.00574	CbGpPWpGaD
Isradipine—Insomnia—Methylprednisolone—multiple sclerosis	0.000665	0.00134	CcSEcCtD
Isradipine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000662	0.00133	CcSEcCtD
Isradipine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000662	0.00133	CcSEcCtD
Isradipine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000661	0.00133	CcSEcCtD
Isradipine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000661	0.00133	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—multiple sclerosis	0.00066	0.00133	CcSEcCtD
Isradipine—Anaemia—Prednisone—multiple sclerosis	0.00066	0.00133	CcSEcCtD
Isradipine—Shock—Dexamethasone—multiple sclerosis	0.000658	0.00133	CcSEcCtD
Isradipine—Shock—Betamethasone—multiple sclerosis	0.000658	0.00133	CcSEcCtD
Isradipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000657	0.00132	CcSEcCtD
Isradipine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000656	0.00132	CcSEcCtD
Isradipine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000656	0.00132	CcSEcCtD
Isradipine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000655	0.00132	CcSEcCtD
Isradipine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000655	0.00132	CcSEcCtD
Isradipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000653	0.00131	CcSEcCtD
Isradipine—Tachycardia—Betamethasone—multiple sclerosis	0.000653	0.00131	CcSEcCtD
Isradipine—Angioedema—Prednisone—multiple sclerosis	0.000652	0.00131	CcSEcCtD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000649	0.00559	CbGpPWpGaD
Isradipine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000649	0.00131	CcSEcCtD
Isradipine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000648	0.0013	CcSEcCtD
Isradipine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000647	0.0013	CcSEcCtD
Isradipine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000647	0.0013	CcSEcCtD
Isradipine—Malaise—Prednisone—multiple sclerosis	0.000644	0.0013	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—multiple sclerosis	0.00064	0.00129	CcSEcCtD
Isradipine—Syncope—Prednisone—multiple sclerosis	0.00064	0.00129	CcSEcCtD
Isradipine—Urticaria—Prednisolone—multiple sclerosis	0.000637	0.00128	CcSEcCtD
Isradipine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000636	0.00128	CcSEcCtD
Isradipine—Fatigue—Triamcinolone—multiple sclerosis	0.000636	0.00128	CcSEcCtD
Isradipine—Fatigue—Methylprednisolone—multiple sclerosis	0.000634	0.00128	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000628	0.00541	CbGpPWpGaD
Isradipine—Loss of consciousness—Prednisone—multiple sclerosis	0.000627	0.00126	CcSEcCtD
Isradipine—Hypotension—Betamethasone—multiple sclerosis	0.000625	0.00126	CcSEcCtD
Isradipine—Hypotension—Dexamethasone—multiple sclerosis	0.000625	0.00126	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—PRNP—multiple sclerosis	0.000624	0.00538	CbGpPWpGaD
Isradipine—Angiopathy—Methotrexate—multiple sclerosis	0.000622	0.00125	CcSEcCtD
Isradipine—Vomiting—Mitoxantrone—multiple sclerosis	0.000621	0.00125	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—multiple sclerosis	0.000619	0.00125	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000618	0.00124	CcSEcCtD
Isradipine—Rash—Mitoxantrone—multiple sclerosis	0.000616	0.00124	CcSEcCtD
Isradipine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000616	0.00124	CcSEcCtD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000615	0.0053	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000615	0.0053	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000615	0.0053	CbGpPWpGaD
Isradipine—Headache—Mitoxantrone—multiple sclerosis	0.000612	0.00123	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00061	0.00123	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00061	0.00123	CcSEcCtD
Isradipine—Arthralgia—Prednisone—multiple sclerosis	0.000608	0.00122	CcSEcCtD
Isradipine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000608	0.00122	CcSEcCtD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000607	0.00523	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000607	0.00523	CbGpPWpGaD
Isradipine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000606	0.00122	CcSEcCtD
Isradipine—Anxiety—Prednisone—multiple sclerosis	0.000606	0.00122	CcSEcCtD
Isradipine—Insomnia—Dexamethasone—multiple sclerosis	0.000605	0.00122	CcSEcCtD
Isradipine—Insomnia—Betamethasone—multiple sclerosis	0.000605	0.00122	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000604	0.00122	CcSEcCtD
Isradipine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000601	0.00121	CcSEcCtD
Isradipine—Paraesthesia—Betamethasone—multiple sclerosis	0.000601	0.00121	CcSEcCtD
Isradipine—Discomfort—Prednisone—multiple sclerosis	0.0006	0.00121	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—multiple sclerosis	0.0006	0.00121	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—multiple sclerosis	0.000597	0.0012	CcSEcCtD
Isradipine—CACNB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000596	0.00514	CbGpPWpGaD
Isradipine—Dyspepsia—Betamethasone—multiple sclerosis	0.000589	0.00119	CcSEcCtD
Isradipine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000589	0.00119	CcSEcCtD
Isradipine—Urticaria—Triamcinolone—multiple sclerosis	0.000586	0.00118	CcSEcCtD
Isradipine—Urticaria—Methylprednisolone—multiple sclerosis	0.000584	0.00118	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.000583	0.00502	CbGpPWpGaD
Isradipine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000583	0.00117	CcSEcCtD
Isradipine—Oedema—Prednisone—multiple sclerosis	0.000583	0.00117	CcSEcCtD
Isradipine—Decreased appetite—Betamethasone—multiple sclerosis	0.000582	0.00117	CcSEcCtD
Isradipine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000582	0.00117	CcSEcCtD
Isradipine—Nausea—Mitoxantrone—multiple sclerosis	0.00058	0.00117	CcSEcCtD
Isradipine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000578	0.00116	CcSEcCtD
Isradipine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000578	0.00116	CcSEcCtD
Isradipine—Back pain—Methotrexate—multiple sclerosis	0.000577	0.00116	CcSEcCtD
Isradipine—Fatigue—Dexamethasone—multiple sclerosis	0.000577	0.00116	CcSEcCtD
Isradipine—Fatigue—Betamethasone—multiple sclerosis	0.000577	0.00116	CcSEcCtD
Isradipine—Shock—Prednisone—multiple sclerosis	0.000573	0.00115	CcSEcCtD
Isradipine—CACNA1H—Axon guidance—PTPRC—multiple sclerosis	0.000572	0.00493	CbGpPWpGaD
Isradipine—Nervous system disorder—Prednisone—multiple sclerosis	0.000571	0.00115	CcSEcCtD
Isradipine—Tachycardia—Prednisone—multiple sclerosis	0.000569	0.00114	CcSEcCtD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000568	0.00489	CbGpPWpGaD
Isradipine—Skin disorder—Prednisone—multiple sclerosis	0.000566	0.00114	CcSEcCtD
Isradipine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000563	0.00113	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—multiple sclerosis	0.000562	0.00113	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—IL1B—multiple sclerosis	0.000561	0.00483	CbGpPWpGaD
Isradipine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000554	0.00111	CcSEcCtD
Isradipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000552	0.00475	CbGpPWpGaD
Isradipine—Anaemia—Methotrexate—multiple sclerosis	0.000551	0.00111	CcSEcCtD
Isradipine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000551	0.00111	CcSEcCtD
Isradipine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000551	0.00111	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—SRM—multiple sclerosis	0.000547	0.00472	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.00054	0.00465	CbGpPWpGaD
Isradipine—Malaise—Methotrexate—multiple sclerosis	0.000538	0.00108	CcSEcCtD
Isradipine—CACNB2—Axon guidance—PRNP—multiple sclerosis	0.000535	0.00461	CbGpPWpGaD
Isradipine—Leukopenia—Methotrexate—multiple sclerosis	0.000534	0.00108	CcSEcCtD
Isradipine—Urticaria—Betamethasone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Isradipine—Urticaria—Dexamethasone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000531	0.00107	CcSEcCtD
Isradipine—Dizziness—Prednisolone—multiple sclerosis	0.00053	0.00107	CcSEcCtD
Isradipine—Asthenia—Triamcinolone—multiple sclerosis	0.000529	0.00107	CcSEcCtD
Isradipine—Asthenia—Methylprednisolone—multiple sclerosis	0.000528	0.00106	CcSEcCtD
Isradipine—Insomnia—Prednisone—multiple sclerosis	0.000527	0.00106	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—PRNP—multiple sclerosis	0.000525	0.00452	CbGpPWpGaD
Isradipine—Paraesthesia—Prednisone—multiple sclerosis	0.000523	0.00105	CcSEcCtD
Isradipine—Pruritus—Triamcinolone—multiple sclerosis	0.000522	0.00105	CcSEcCtD
Isradipine—Cough—Methotrexate—multiple sclerosis	0.000521	0.00105	CcSEcCtD
Isradipine—Pruritus—Methylprednisolone—multiple sclerosis	0.00052	0.00105	CcSEcCtD
Isradipine—Dyspepsia—Prednisone—multiple sclerosis	0.000513	0.00103	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—multiple sclerosis	0.000508	0.00102	CcSEcCtD
Isradipine—Chest pain—Methotrexate—multiple sclerosis	0.000508	0.00102	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—PRNP—multiple sclerosis	0.000507	0.00437	CbGpPWpGaD
Isradipine—Decreased appetite—Prednisone—multiple sclerosis	0.000506	0.00102	CcSEcCtD
Isradipine—Rash—Prednisolone—multiple sclerosis	0.000506	0.00102	CcSEcCtD
Isradipine—Dermatitis—Prednisolone—multiple sclerosis	0.000505	0.00102	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000504	0.00102	CcSEcCtD
Isradipine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000503	0.00101	CcSEcCtD
Isradipine—Fatigue—Prednisone—multiple sclerosis	0.000502	0.00101	CcSEcCtD
Isradipine—Headache—Prednisolone—multiple sclerosis	0.000502	0.00101	CcSEcCtD
Isradipine—Discomfort—Methotrexate—multiple sclerosis	0.000502	0.00101	CcSEcCtD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000498	0.00429	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000498	0.00429	CbGpPWpGaD
Isradipine—Constipation—Prednisone—multiple sclerosis	0.000498	0.001	CcSEcCtD
Isradipine—Dizziness—Triamcinolone—multiple sclerosis	0.000488	0.000982	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000487	0.00098	CcSEcCtD
Isradipine—Dizziness—Methylprednisolone—multiple sclerosis	0.000486	0.00098	CcSEcCtD
Isradipine—CACNA1S—Axon guidance—PTPRC—multiple sclerosis	0.000485	0.00418	CbGpPWpGaD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000482	0.00415	CbGpPWpGaD
Isradipine—Feeling abnormal—Prednisone—multiple sclerosis	0.00048	0.000967	CcSEcCtD
Isradipine—Asthenia—Betamethasone—multiple sclerosis	0.00048	0.000966	CcSEcCtD
Isradipine—Asthenia—Dexamethasone—multiple sclerosis	0.00048	0.000966	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000477	0.000961	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000477	0.00096	CcSEcCtD
Isradipine—Nausea—Prednisolone—multiple sclerosis	0.000476	0.000959	CcSEcCtD
Isradipine—Pruritus—Betamethasone—multiple sclerosis	0.000473	0.000953	CcSEcCtD
Isradipine—Pruritus—Dexamethasone—multiple sclerosis	0.000473	0.000953	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—multiple sclerosis	0.000473	0.000952	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000471	0.000948	CcSEcCtD
Isradipine—Vomiting—Triamcinolone—multiple sclerosis	0.000469	0.000944	CcSEcCtD
Isradipine—Vomiting—Methylprednisolone—multiple sclerosis	0.000468	0.000942	CcSEcCtD
Isradipine—Rash—Triamcinolone—multiple sclerosis	0.000465	0.000936	CcSEcCtD
Isradipine—Dermatitis—Triamcinolone—multiple sclerosis	0.000464	0.000935	CcSEcCtD
Isradipine—Rash—Methylprednisolone—multiple sclerosis	0.000464	0.000934	CcSEcCtD
Isradipine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000463	0.000933	CcSEcCtD
Isradipine—Urticaria—Prednisone—multiple sclerosis	0.000463	0.000932	CcSEcCtD
Isradipine—Headache—Triamcinolone—multiple sclerosis	0.000462	0.00093	CcSEcCtD
Isradipine—Headache—Methylprednisolone—multiple sclerosis	0.000461	0.000928	CcSEcCtD
Isradipine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000458	0.000922	CcSEcCtD
Isradipine—Diarrhoea—Betamethasone—multiple sclerosis	0.000458	0.000922	CcSEcCtD
Isradipine—CACNB2—Neuronal System—BCHE—multiple sclerosis	0.000457	0.00394	CbGpPWpGaD
Isradipine—CACNA1D—Alzheimers Disease—IL1B—multiple sclerosis	0.000455	0.00392	CbGpPWpGaD
Isradipine—Hypotension—Methotrexate—multiple sclerosis	0.000455	0.000916	CcSEcCtD
Isradipine—CACNA1H—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000455	0.00392	CbGpPWpGaD
Isradipine—CACNA1H—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000446	0.00384	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—PRNP—multiple sclerosis	0.000445	0.00384	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000445	0.00384	CbGpPWpGaD
Isradipine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000444	0.000893	CcSEcCtD
Isradipine—Dizziness—Betamethasone—multiple sclerosis	0.000442	0.000891	CcSEcCtD
Isradipine—Dizziness—Dexamethasone—multiple sclerosis	0.000442	0.000891	CcSEcCtD
Isradipine—Insomnia—Methotrexate—multiple sclerosis	0.00044	0.000887	CcSEcCtD
Isradipine—Nausea—Triamcinolone—multiple sclerosis	0.000438	0.000882	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—multiple sclerosis	0.000437	0.00088	CcSEcCtD
Isradipine—Nausea—Methylprednisolone—multiple sclerosis	0.000437	0.00088	CcSEcCtD
Isradipine—CACNA1H—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000436	0.00376	CbGpPWpGaD
Isradipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000434	0.000874	CcSEcCtD
Isradipine—Somnolence—Methotrexate—multiple sclerosis	0.000433	0.000872	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—multiple sclerosis	0.000429	0.000863	CcSEcCtD
Isradipine—CACNA1S—Alzheimers Disease—MAPK1—multiple sclerosis	0.000427	0.00368	CbGpPWpGaD
Isradipine—Vomiting—Betamethasone—multiple sclerosis	0.000425	0.000856	CcSEcCtD
Isradipine—Vomiting—Dexamethasone—multiple sclerosis	0.000425	0.000856	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—multiple sclerosis	0.000423	0.000852	CcSEcCtD
Isradipine—Rash—Dexamethasone—multiple sclerosis	0.000422	0.000849	CcSEcCtD
Isradipine—Rash—Betamethasone—multiple sclerosis	0.000422	0.000849	CcSEcCtD
Isradipine—Dermatitis—Dexamethasone—multiple sclerosis	0.000421	0.000849	CcSEcCtD
Isradipine—Dermatitis—Betamethasone—multiple sclerosis	0.000421	0.000849	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00042	0.000846	CcSEcCtD
Isradipine—Fatigue—Methotrexate—multiple sclerosis	0.00042	0.000845	CcSEcCtD
Isradipine—Headache—Dexamethasone—multiple sclerosis	0.000419	0.000844	CcSEcCtD
Isradipine—Headache—Betamethasone—multiple sclerosis	0.000419	0.000844	CcSEcCtD
Isradipine—Asthenia—Prednisone—multiple sclerosis	0.000418	0.000842	CcSEcCtD
Isradipine—CACNB2—Axon guidance—PTPRC—multiple sclerosis	0.000416	0.00358	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000413	0.00356	CbGpPWpGaD
Isradipine—Pruritus—Prednisone—multiple sclerosis	0.000412	0.00083	CcSEcCtD
Isradipine—CACNA1H—Developmental Biology—PTPRC—multiple sclerosis	0.000408	0.00352	CbGpPWpGaD
Isradipine—CACNA1S—Alzheimers Disease—TNF—multiple sclerosis	0.000407	0.00351	CbGpPWpGaD
Isradipine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000401	0.000808	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	0.0004	0.00345	CbGpPWpGaD
Isradipine—Diarrhoea—Prednisone—multiple sclerosis	0.000399	0.000803	CcSEcCtD
Isradipine—Nausea—Dexamethasone—multiple sclerosis	0.000397	0.0008	CcSEcCtD
Isradipine—Nausea—Betamethasone—multiple sclerosis	0.000397	0.0008	CcSEcCtD
Isradipine—CACNA1D—Axon guidance—PTPRC—multiple sclerosis	0.000394	0.00339	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000391	0.00337	CbGpPWpGaD
Isradipine—Urticaria—Methotrexate—multiple sclerosis	0.000387	0.000779	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—CYP24A1—multiple sclerosis	0.000386	0.00332	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP27B1—multiple sclerosis	0.000386	0.00332	CbGpPWpGaD
Isradipine—Dizziness—Prednisone—multiple sclerosis	0.000385	0.000776	CcSEcCtD
Isradipine—CACNB2—Developmental Biology—PRNP—multiple sclerosis	0.000382	0.00329	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SRM—multiple sclerosis	0.000375	0.00323	CbGpPWpGaD
Isradipine—Vomiting—Prednisone—multiple sclerosis	0.00037	0.000746	CcSEcCtD
Isradipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.00037	0.00319	CbGpPWpGaD
Isradipine—Rash—Prednisone—multiple sclerosis	0.000367	0.00074	CcSEcCtD
Isradipine—Dermatitis—Prednisone—multiple sclerosis	0.000367	0.000739	CcSEcCtD
Isradipine—Headache—Prednisone—multiple sclerosis	0.000365	0.000735	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—PRNP—multiple sclerosis	0.000361	0.00312	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SRM—multiple sclerosis	0.000355	0.00306	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GPC5—multiple sclerosis	0.000353	0.00304	CbGpPWpGaD
Isradipine—Asthenia—Methotrexate—multiple sclerosis	0.000349	0.000703	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—MAPK1—multiple sclerosis	0.000347	0.00299	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—PTPRC—multiple sclerosis	0.000346	0.00298	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	0.000346	0.00298	CbGpPWpGaD
Isradipine—Nausea—Prednisone—multiple sclerosis	0.000346	0.000697	CcSEcCtD
Isradipine—Pruritus—Methotrexate—multiple sclerosis	0.000344	0.000694	CcSEcCtD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000344	0.00296	CbGpPWpGaD
Isradipine—Diarrhoea—Methotrexate—multiple sclerosis	0.000333	0.000671	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TNF—multiple sclerosis	0.00033	0.00285	CbGpPWpGaD
Isradipine—Dizziness—Methotrexate—multiple sclerosis	0.000322	0.000648	CcSEcCtD
Isradipine—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	0.000318	0.00274	CbGpPWpGaD
Isradipine—CACNB2—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000317	0.00274	CbGpPWpGaD
Isradipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000317	0.00273	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SRM—multiple sclerosis	0.000312	0.00269	CbGpPWpGaD
Isradipine—Vomiting—Methotrexate—multiple sclerosis	0.00031	0.000623	CcSEcCtD
Isradipine—Rash—Methotrexate—multiple sclerosis	0.000307	0.000618	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—multiple sclerosis	0.000307	0.000618	CcSEcCtD
Isradipine—Headache—Methotrexate—multiple sclerosis	0.000305	0.000614	CcSEcCtD
Isradipine—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	0.000305	0.00263	CbGpPWpGaD
Isradipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000301	0.00259	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—PTPRC—multiple sclerosis	0.000297	0.00256	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—RRM1—multiple sclerosis	0.000292	0.00252	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	0.00029	0.0025	CbGpPWpGaD
Isradipine—Nausea—Methotrexate—multiple sclerosis	0.000289	0.000582	CcSEcCtD
Isradipine—CACNA1D—Developmental Biology—PTPRC—multiple sclerosis	0.000281	0.00242	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000265	0.00228	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000265	0.00228	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP27B1—multiple sclerosis	0.000264	0.00228	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP24A1—multiple sclerosis	0.000264	0.00228	CbGpPWpGaD
Isradipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	0.000264	0.00228	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000261	0.00225	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000261	0.00225	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—TYK2—multiple sclerosis	0.000256	0.0022	CbGpPWpGaD
Isradipine—CACNA2D2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000254	0.00219	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP27B1—multiple sclerosis	0.00025	0.00216	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP24A1—multiple sclerosis	0.00025	0.00216	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	0.000247	0.00213	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GPC5—multiple sclerosis	0.000242	0.00208	CbGpPWpGaD
Isradipine—Clevidipine—BCHE—multiple sclerosis	0.000233	1	CrCbGaD
Isradipine—CACNA1D—Metabolism—GPC5—multiple sclerosis	0.000229	0.00197	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	0.00022	0.0019	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	0.00022	0.0019	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—TYK2—multiple sclerosis	0.000217	0.00187	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MMP9—multiple sclerosis	0.000202	0.00174	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GPC5—multiple sclerosis	0.000201	0.00173	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—RRM1—multiple sclerosis	0.0002	0.00173	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—MAPK1—multiple sclerosis	0.000195	0.00168	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—RRM1—multiple sclerosis	0.00019	0.00163	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—TYK2—multiple sclerosis	0.000186	0.0016	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TYK2—multiple sclerosis	0.000183	0.00157	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—TYK2—multiple sclerosis	0.000176	0.00152	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000174	0.0015	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP9—multiple sclerosis	0.000171	0.00147	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—BCHE—multiple sclerosis	0.000168	0.00145	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—RRM1—multiple sclerosis	0.000167	0.00144	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—MAPK1—multiple sclerosis	0.000163	0.0014	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TYK2—multiple sclerosis	0.000155	0.00134	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—TYK2—multiple sclerosis	0.000155	0.00133	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—multiple sclerosis	0.000147	0.00126	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—multiple sclerosis	0.000144	0.00124	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—multiple sclerosis	0.000139	0.0012	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000138	0.00119	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MAPK1—multiple sclerosis	0.000138	0.00119	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—MAPK1—multiple sclerosis	0.000134	0.00115	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TYK2—multiple sclerosis	0.000133	0.00114	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—STAT3—multiple sclerosis	0.000128	0.0011	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TYK2—multiple sclerosis	0.000126	0.00108	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—multiple sclerosis	0.000125	0.00108	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—multiple sclerosis	0.000122	0.00105	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—multiple sclerosis	0.000122	0.00105	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TGFB1—multiple sclerosis	0.000119	0.00102	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK1—multiple sclerosis	0.000118	0.00102	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK1—multiple sclerosis	0.000116	0.001	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—BCHE—multiple sclerosis	0.000115	0.000992	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK1—multiple sclerosis	0.000112	0.000967	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000112	0.000966	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—multiple sclerosis	0.000111	0.000954	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	0.000111	0.000952	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—BCHE—multiple sclerosis	0.000109	0.000939	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	0.000108	0.000935	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—multiple sclerosis	0.000106	0.000915	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—multiple sclerosis	0.000105	0.000901	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—APOE—multiple sclerosis	0.000101	0.00087	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	0.000101	0.000867	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	9.91e-05	0.000854	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	9.86e-05	0.00085	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	9.86e-05	0.00085	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—BCHE—multiple sclerosis	9.57e-05	0.000825	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—multiple sclerosis	9.39e-05	0.000809	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—multiple sclerosis	9.3e-05	0.000801	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—multiple sclerosis	9.1e-05	0.000785	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—multiple sclerosis	8.93e-05	0.00077	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	8.81e-05	0.000759	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	8.7e-05	0.00075	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—POMC—multiple sclerosis	8.68e-05	0.000748	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—multiple sclerosis	8.62e-05	0.000743	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TGFB1—multiple sclerosis	8.62e-05	0.000743	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK1—multiple sclerosis	8.45e-05	0.000729	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	8.16e-05	0.000704	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—multiple sclerosis	8.05e-05	0.000694	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	8.01e-05	0.00069	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—multiple sclerosis	7.91e-05	0.000682	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	7.74e-05	0.000667	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—multiple sclerosis	7.62e-05	0.000657	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—multiple sclerosis	7.58e-05	0.000653	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—multiple sclerosis	7.58e-05	0.000653	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	7.17e-05	0.000618	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	7.04e-05	0.000606	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—APOE—multiple sclerosis	6.92e-05	0.000596	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—multiple sclerosis	6.7e-05	0.000577	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—APOE—multiple sclerosis	6.56e-05	0.000565	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—multiple sclerosis	6.5e-05	0.00056	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SRM—multiple sclerosis	6.42e-05	0.000554	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—multiple sclerosis	6.15e-05	0.00053	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.95e-05	0.000513	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—POMC—multiple sclerosis	5.95e-05	0.000512	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—APOE—multiple sclerosis	5.76e-05	0.000496	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—POMC—multiple sclerosis	5.63e-05	0.000485	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—multiple sclerosis	5.42e-05	0.000467	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—multiple sclerosis	5.41e-05	0.000466	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—multiple sclerosis	5.13e-05	0.000442	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—POMC—multiple sclerosis	4.95e-05	0.000426	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.53e-05	0.00039	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.53e-05	0.00039	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—multiple sclerosis	4.51e-05	0.000389	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.14e-05	0.000357	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.43e-05	0.000296	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.97e-05	0.00017	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.19e-05	0.000102	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.02e-05	8.77e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—multiple sclerosis	9.28e-06	8e-05	CbGpPWpGaD
